About: acn

SAN FRANCISCO, CA, July 18, 2025 - (ACN Newswire via SeaPRwire.com) - The first Belgian aircrew has completed training to operate the world's leading remotely piloted aircraft (RPA): the MQ-9B SkyGuardian®. General Atomics Aeronautical Systems, Inc. (GA-ASI), designer and developer of the MQ-9B, provided the extensive aircrew training that culminated at GA-ASI's Desert Horizon test facility in El Mirage, California, following stops in Belgium and GA-ASI's Flight Test & Training Center in North Dakota."Providing all-encompassing training for the aircrews of our customers goes hand in hand with delivering the world's most capable RPA," said GA-ASI President David R. Alexander. "Completing this training ensures that Belgium is ready and able to operate their MQ-9Bs and maximize the benefits that come from long-range, high-endurance RPA."The scope of the training is focused on the foundational skills required to operate the MQ-9B SkyGuardian air vehicle and its equipment, including the Multi-Spectral Targeting System (MTS), Synthetic Aperture Radar (SAR), Mission Intelligence Station (MIS), and System for Tasking and Real-Time Exploitation (STARE). Training involves building solid foundations for both normal and emergency operations in Intelligence, Surveillance, and Reconnaissance (ISR) systems, instrument flying, and Automatic Takeoff and Landing Capability (ATLC) and more.The first flight of Belgium's initial MQ-9B aircraft took place in February. That aircraft will soon complete Acceptance Test Procedures and is expected to be in Belgium before the end of September. It's the first of a four-aircraft purchase by the Belgian Ministry of Defence. The Foreign Military Sale to Belgium also includes two Certified Ground Control Stations.MQ-9B is the world's most advanced RPA system, delivering exceptionally long endurance and range - with ATLC under pole-to-pole SATCOM-only control - and will be able to operate in unsegregated airspace using the GA-ASI-developed Detect and Avoid system. MQ-9B includes the SkyGuardian and SeaGuardian® models, with multiple deliveries made to the U.K.'s Royal Air Force (Protector), as well as orders from Canada, Poland, Japan, Taiwan, India, and the U.S. Air Force in support of the Special Operations Command. MQ-9B has also supported various U.S. Navy exercises, including Northern Edge, Integrated Battle Problem, and Group Sail.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 8 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com.

SAN DIEGO, CA, July 18, 2025 - (ACN Newswire via SeaPRwire.com) - General Atomics Aeronautical Systems, Inc. (GA-ASI) and General Atomics Integrated Intelligence, Inc. (GA-Intelligence) successfully completed a groundbreaking demonstration on July 8, integrating technologies across multiple affiliates to showcase long-range kill chain effects, including an autonomous air-to-air engagement. The flight integrated local and global sensor fusion to deliver real-time situational awareness and autonomous tasking to an airborne MQ-20 Avenger® through the Tactical Autonomy Core Ecosystem (TacACE) to close the kill chain and showcase the system's maturity and operational readiness for the warfighter.The event featured the integration of a Collaborative Combat Aircraft (CCA), a fully compliant government-owned autonomy implementation, and beyond-line-of-sight (BLOS) Command and Control (C2). The MQ-20 unmanned jet, furnished by GA-ASI, acted as a CCA surrogate in a sensor Emission Control (EMCON) environment. It was operated autonomously and controlled using distributed-edge C2 nodes powered by Optix.C2 and Omniview software. Optix.C2, a product from General Atomics-Intelligence, provided low-latency, localized C2 functionality while remaining networked to the broader operational picture, enabling real-time coordination across multiple domains.Dr. Brian Ralston, President of GA-Intelligence, applauded the joint effort. "This demonstration illustrates the value of integrating cutting-edge and proven technologies across the GA enterprise. The Optix data platform and C2 capability enable rapid integration and experimentation to address critical DoD and IC needs."General Atomics successfully fused space-based sensing and tactical sensing with the C2 node during the flight, giving the aircraft access to a complete real-time threat picture for enhanced onboard autonomous decision-making. The demonstration also included live coordination of Intelligence, Surveillance, and Reconnaissance (ISR) and kinetic tasking through a unified operator interface capable of deployment in virtually any cloud environment.During the exercise, the live MQ-20 aircraft autonomously patrolled a designated Combat Air Patrol (CAP) zone, leveraging off-board sensors to demonstrate how passive collection techniques can inform autonomous platforms in real time. Four CCA surrogates - one live and three virtual - were directed by an operator to investigate multiple targets of interest. Upon identifying them as threats, the operator issued a command to initiate the BLOS engagement. The autonomous systems maneuvered into position, simulated missile launches, assessed battle damage, and returned to CAP without additional operator input."This demonstration represents a substantial leap in autonomy and human-machine interfaces that are critical to the warfighter in the near-peer fight," said Michael Atwood, Vice President of Advanced Programs at GA-ASI. "By integrating Optix.C2 with TacACE, we're delivering a system that not only operates at the tactical edge but also enables rapid decision-making and execution across the battlespace. This is the future of warfare - scalable, autonomous systems that empower the warfighter to dominate at range."GA-ASI continues to develop and validate autonomy products that deliver scalable, collaborative aircraft behavior with minimal operator input. GA-Intelligence provided multi-sensor global fusion and engagement orchestration algorithms and interfaces. This latest milestone expands the company's autonomy portfolio with access to a complete threat picture while advancing critical-edge C2 capabilities and intuitive operator interfaces.About GA-ASIGeneral Atomics Aeronautical Systems, Inc. is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 8 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.About GA-IntelligenceGeneral Atomics Integrated Intelligence, Inc. is a data science, software development, and systems engineering firm focused on developing advanced analytic capabilities to customers in both public and private sectors, with a strong emphasis on tools in support of spatio-temporal (space and time) data management, multi-source/multi-INT correlation and data fusion, tracking, entity resolution, location forecasting, and multi-domain global situational awareness (MDGSA) leveraging extremely high volume/velocity data sources. For more information, visit www.ga-intelligence.com.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年7月16日 - (亚太商讯 via SeaPRwire.com) - 小黄鸭德盈控股国际有限公司（及其下属公司合称为「小黄鸭德盈」或「集团」或「B.Duck 小黄鸭」，股份代号：2250）于2025年7月16日，携全新IP及强势阵容亮相于上海国家会展中心举行的，汇聚400余家展商的全球授权展（LEC)上海站，并成功举办集团全新IP推介会。是次展会云集超过四百家参展商，场面盛大。集团创始人许夏林先生亲临现场并发表开幕致辞，创新事业部总经理谭欢欢女士作为主推介人，向全球合作伙伴及业界同仁介绍了包括「抓大鹅」、「好好家族」、「凹凸世界」、「Milolo」、「Cimmy」、「The SLLO」、「Hurobo」及「Diudiubaby」在内的全新IP 矩阵。此次新IP集中亮相，标志着小黄鸭德盈作为中国最大的角色IP授权公司，其核心IP资产持续战略性扩充，产业生态链构建步入深化完善的新阶段。（小黄鸭德盈集团新IP推介会现场嘉宾合影）三大战略驱动增长，20周年再启新里程许夏林先生在开幕致辞中回顾了B.Duck小黄鸭20年的发展历程，并系统阐述了公司的三大核心发展战略：一是IP+文化：小黄鸭德盈秉持「文化自信」与「国际化」双主线，旗下IP B.Duck已成功与故宫宫廷文化、贵州少数民族文化、大英博物馆、陈粉丸剪纸艺术及三丽鸥、Monchichi、熊本熊等海内外知名文化IP联名合作，持续拓展文化内涵。同时围绕「Make A Playful World」理念，集团积极布局国民游戏IP、动漫IP及传统文化IP，构建多元生态矩阵。二是IP+商品零售：聚焦「年轻人情绪价值」与「美好生活追求」，覆盖亲子母婴、泛潮玩及趣味家居生活领域，小黄鸭德盈通过自建「自研、自产、自销」全链条运营体系，实现线上线下协同发展，以产品驱动粉丝价值。三是IP+文旅：小黄鸭德盈以「Be Playful」为核心精神，全面深化文旅产业布局。集团通过打造主题乐园、城市乐园、地方文旅合作及城市主题活动等多元化场景，幷配套开发专属产品线、创意快闪店等特色项目，构建出兼具趣味性与可持续发展的IP文旅生态系统。目前文旅项目均表现亮眼，比如深圳万象前海B.Duck小黄鸭城市乐园2025年5至6月累计充值金额近200万元人民币，充分展现IP线下体验的强大吸金能力与市场热度。小黄鸭德盈集团创始人许夏林先生强调：「站在B.Duck品牌20周年的重要里程碑，小黄鸭德盈将以更宏大的格局持续扩充IP矩阵，不仅深耕现有核心IP价值，更将积极孵化具有市场潜力的新锐IP；同时全面深化从IP孵化、内容创作、授权合作到衍生品开发的全产业链运营能力，透过线上线下生态系统的战略协同，为全球消费者打造更具沉浸感的文化娱乐体验；集团也将持续创新商业模式，透过多元化的授权合作、主题空间打造及数字化营销等创新方式，为合作伙伴开拓更广阔的商业发展空间，实现品牌价值与商业价值的共赢成长。」（小黄鸭德盈集团创始人许夏林）新IP矩阵深度解析：覆盖多元场景，实力有据随后，谭欢欢女士结合详实资料与案例，对新IP矩阵下的8 IP进行了详细的介绍，她表示：「抓大鹅IP」是国民级游戏IP，作为2024至2025年间现象级休闲游戏代表，累积拥有3亿玩家及800万日活用户基础。集团携手开发团队，从零孵化IP形象 - 一只「偷感十足」、「神出鬼没」的顽皮大鹅，精准契合年轻人追求「爽感」的情绪价值，依托庞大粉丝群构建IP生态系统。「好好家族」是情绪基因IP，以「好好」为名，传递赞美与祝福。透过鲜明配色与简约设计跃动快乐基因，该IP已携手娇韵诗、Kappa等品牌深耕插画、线下活动及茶饮赛道。「凹凸世界」作为00后最爱国漫热血IP之一，以独特3D风格与高燃剧情积累全网千万粉丝，四季总播放量高达约20亿。线下快闪活动、粉丝活动持续引爆Z世代圈层热度。「Milolo」是梦幻形象IP，以「瞌睡症小女孩」形象打造梦境与现实交织的奇幻世界。此前与B.Duck联名已成经典案例，与QQ音乐合作主题首月吸引30万人使用。「Cimmy」、「The SLLO」、「Hurobo」与「Diudiubaby」作为集团战略合作伙伴Hidden Wooo 旗下的潮酷萌系IP，商业表现亮眼。「Cimmy」拥有稳固的私域粉丝社群，并在大众平台累积录得千万级曝光；其首发盲盒产品共推出20万只，短时间内即告售罄，潮玩大尺寸产品于二级市场溢价超过原价十倍。源自韩国艺术家简约有趣设计的「The SLLO」，线上曝光量超6000万，盲盒产品销售额突破7000万元。「Hurobo」和「Diudiubaby」是新锐萌系男孩IP，已积累庞大私域社群用户，相关平台话题浏览量超千万级。（小黄鸭和新IP）谭欢欢女士表示：「小黄鸭德盈的新IP矩阵绝非简单迭加，而是对生态版图的战略升级。它们覆盖从低幼到成人、大众娱乐到垂直圈层、线上内容到线下体验的全维度，为合作伙伴提供更多精准多元、极具商业爆发力的IP赋能新方向。」深化生态布局，巩固IP龙头地位此次LEC上海站上的新IP集体首秀，是小黄鸭德盈「大IP生态」战略深化落地的关键里程碑。作为港股上市公司，集团依托资本优势与专业运营能力，加速构建覆盖IP孵化、内容创作、全球授权、衍生品开发、主题空间及数位行销的全产业链闭环。通过持续完善的生态体系，集团致力为消费者创造极致文化体验，为合作伙伴提供可持续增长价值，巩固其作为IP生态运营商的领先地位。多元IP矩阵扩容与产业生态完善，正驱动小黄鸭德盈驶向更广阔的新蓝海。关于小黄鸭德盈控股国际有限公司小黄鸭德盈控股国际有限公司是一家主要从事角色知识产权业务的投资控股公司。集团自 2005 年创立明星 IP「B.Duck 小黄鸭」以来，在 IP 各类授权及运营上拥有丰富经验。集团着力于 IP 实景文旅、游戏文娱、商品零售、跨境出海等业务增长点，实现IP授权、商品企划、供应链、销售渠道等业务板块的优化整合，小黄鸭德盈不断深化 IP 商业化生态圈建设，致力打造 B.Duck 成为「全球快乐符号」，推动「Make A Playful World」的使命落地。 Copyright 2025 亚太商讯 via SeaPRwire.com.

罗密维尔，伊利诺伊州, 2025年7月16日 - (亚太商讯 via SeaPRwire.com) - 作为高性能材料分销领域的领先企业，Formerra 今日宣布与 GEON® Performance Solutions 达成合作协议，指定 acquisition of Foster, LLC, 医用化合物在北美和南美的首选分销商。该协议建立在 GEON 收购 Foster, LLC 的基础上，同时延续了 Formerra 与 GEON 在柔性与刚性 PVC 及填充聚丙烯材料方面的长期全球合作关系。Formerra 关键客户副总裁 Kelly Wessner 表示：“这项扩展合作将为我们的客户提供更广泛、经过验证的医疗级解决方案，同时依托 Formerra 的技术支持与强大的供应链能力。Foster 品牌的影响力以及 GEON 的持续投资，为这些材料及客户带来了强劲的增长潜力。”Foster, LLC 拥有超过 30 年定制医疗聚合物配方的专业经验，提供高度工程化的配方，包括显影型、预着色、USP VI 级别和符合 ISO 10993 标准的产品。其材料广泛应用于医疗器械外壳、药物输送与自动注射装置组件、外科工具和远程患者监测设备等关键领域。GEON 首席商务官 Arthur Adams 表示：“我们很荣幸能为快速增长的医疗与医疗器械行业提供服务。GEON 与 Foster 和 Formerra 的新合作将开启新的旅程，扩大我们的全球足迹，并使我们能向更多客户提供医疗级工程聚合物。”随着 Foster, LLC 化合物产品的加入，Formerra 进一步巩固了其在医疗健康领域的领先地位，通过提供无与伦比的医疗工程聚合物渠道、深入的法规合规专业能力以及覆盖整个美洲的快速物流支持，持续推动行业发展。关键信息-- Formerra 将在北美和南美分销 Foster®, LLC 的医用化合物。-- 此项协议将定制医疗级化合物纳入 Formerra 现有的 GEON® PVC 与填充聚丙烯（PP）材料的全球产品组合中。-- Foster®, LLC 材料广泛应用于医疗器械外壳、药物输送与自动注射装置、外科工具、远程患者监测设备等关键领域。关于 Formerra Formerra 是领先的工程材料分销商，将全球顶级聚合物及特种材料生产商与医疗保健、消费品、工业及移动出行等市场的数千家 OEM 和品牌商紧密相连。凭借技术与商业专业能力，Formerra 提供独特的产品组合深度、强大的供应链实力、深厚的行业知识、卓越的服务、领先的电子商务能力以及创新精神。经验丰富的 Formerra 团队帮助各行业客户以全新且更优的方式设计、选择、加工和开发产品，从而提升性能、生产力、可靠性和可持续性。欲了解更多信息，请访问 www.formerra.com 。关于 GEONGEON® Performance Solutions 是全球领先的高性能聚合物解决方案配方、开发与制造企业。公司拥有适应性极强的乙烯类和聚烯烃类聚合物技术组合，并提供全方位的制造服务，结合三大传统优势，专注于为客户提供一体化解决方案。GEON 在多个市场中积极推动高性能材料的发展与创新，包括家电、建筑与基础设施、电子、医疗、交通、电力与通信等。GEON 拥有约 1,200 名全球员工，在全球设有 15 个世界级制造工厂，总部位于俄亥俄州韦斯特莱克（Westlake, Ohio）。更多信息请访问官网： www.geon.com 。GEON Performance Solutions 是 SK Capital Partners 投资组合公司之一。媒体联系Jackie MorrisMarketing Communications Manager, Formerrajackie.morris@formerra.com来源: Formerra Copyright 2025 亚太商讯 via SeaPRwire.com.

CYBERJAYA, MALAYSIA, July 17, 2025 - (ACN Newswire via SeaPRwire.com) - BlackBerry Limited (NYSE:BB)(TSX:BB) and EC-Council, a global leader in cybersecurity certifications and learning technology, today announced a new partnership that will offer government employees nationwide with increased access to cybersecurity training and certifications through the Cybersecurity Center of Excellence (CCoE) in Malaysia. The collaboration supports Malaysia's pioneering efforts to boost human cyber capital and strengthen the nation's defences against growing digital threats, equipping government employees with advanced, industry-relevant skills through flexible learning modules.In collaboration with the Malaysian Communications and Multimedia Commission (MCMC), the partnership will further expand the CCoE Cybersecurity Curriculum, which already offers a wide range of globally recognized course offerings and certifications. With the addition of the cutting-edge EC-Council Learning (ECL) platform, one of the world's most advanced cloud-based cybersecurity education ecosystems, the CCoE is expanding self-paced online and in-person learning for Malaysian civil servants, helping more men and women to upskill and complete courses in their own time.In support of the Malaysian government's commitment to cybersecurity capacity building, the addition of EC-Council Learning marks a significant evolution of the CCoE's curriculum, enhancing its existing programs with a robust, cloud-based platform to bolster government workforces with world-class skills and qualifications as cyber threats escalate.Jaclyn Sim, Cybersecurity Training Manager for BlackBerry at the Malaysia Cybersecurity Center of Excellence, said, "BlackBerry's partnership with EC-Council represents a meaningful step forward in the shared mission to build a cyber-resilient Malaysia. This initiative builds upon the CCoE's extensive curriculum of online and in-person training, with an advanced, flexible platform that empowers civil servants to learn anytime, anywhere. Together with MCMC, we remain committed to upskilling and fostering a culture of continuous learning across the public sector."Jay Bavisi, Founder and CEO of EC-Council added, "At the heart of this partnership is a shared mission between EC-Council, BlackBerry and the Cybersecurity Center of Excellence to build a cyber-resilient Malaysia by placing trusted, modern cyber learning tools in the hands of every civil servant."Through this initiative, Malaysian civil service professionals will gain access to a full spectrum of programs aligned with national digital ambitions, including:Advanced Cyber Leadership Training: Featuring the globally recognized Certified Chief Information Security Officer (CCISO) program, designed to prepare boardroom-ready executives capable of leading strategic cyber governance and building resilient security operations.Hands-On Technical Skill Development: Delivered through EC-Council's flagship Certified Ethical Hacker (CEH) program and other globally recognized certifications, widely acknowledged as the gold standard in offensive security training.Cyber Essentials for New Entrants: A comprehensive suite of beginner-friendly courses, real-world labs, and interactive Capture-the-Flag (CTF) challenges the largest of its kind globally-designed to onboard new talent into the cybersecurity workforce.This BlackBerry and EC-Council news also coincides with the recent 12-month anniversary of the Cybersecurity Center of Excellence (CCoE), which has rapidly grown into an international hub for cyber talent development, attracting a $3.9M CAD investment from the Government of Canada. Over the past year, the CCoE has launched several initiatives, including multiple partnerships with globally-certified partners such as CompTIA, SANS Institute, ICS2 and Rogers Cybersecure Catalyst, awarded scholarships to aspiring cyber leaders and introduced programs to foster diversity and inclusion in the sector.Find out more about EC-Council courses for Malaysian civil servants at the CCoE via ccoemalaysia@blackberry.com. Visit here for more information about the Malaysia CCoE or follow us on Linkedin.About EC-CouncilThe International Council of E-Commerce Consultants (EC-Council) is a global leader in cybersecurity education, certification, and training. Known for its flagship programs such as Certified Ethical Hacker (CEH) and Certified Chief Information Security Officer (CCISO), EC-Council serves professionals in over 145 countries and is trusted by governments, military agencies, and Fortune 500 companies worldwide.About BlackBerryBlackBerry (NYSE:BB)(TSX:BB) provides enterprises and governments the intelligent software and services that power the world around us. Based in Waterloo, Ontario, the company's high-performance foundational software enables major automakers and industrial giants alike to unlock transformative applications, drive new revenue streams and launch innovative business models, all without sacrificing safety, security, and reliability. With a deep heritage in Secure Communications, BlackBerry delivers operational resiliency with a comprehensive, highly secure, and extensively certified portfolio for mobile fortification, mission-critical communications, and critical events management.For more information, visit BlackBerry.com and follow @BlackBerry.Trademarks, including but not limited to BLACKBERRY and EMBLEM Design, are the trademarks or registered trademarks of BlackBerry Limited, and the exclusive rights to such trademarks are expressly reserved. All other trademarks are the property of their respective owners. BlackBerry is not responsible for any third-party products or services.Media Contacts:BlackBerry Media Relations+1 (519) 597-7273mediarelations@BlackBerry.comMedia Contact - EC-CouncilSean Lim - Senior Vice President (SVP) at EC-Councilsean@eccouncil.orgSOURCE: BlackBerry Copyright 2025 ACN Newswire via SeaPRwire.com.

SHENZHEN, CHINA, July 16, 2025 - (ACN Newswire via SeaPRwire.com) - On the morning of 15 July 2025, China Medical System Holdings Limited (“CMS” or the “Group”) rang the ceremonial bell to mark its official listing on the Singapore Exchange Main Board (Stock Abbreviation: CMS, Stock Code: 8A8).Nearly one hundred representatives from global professional institutions, shareholders, business partners and employees gathered to witness this strategic moment. Following its successful IPO on the Hong Kong Stock Exchange Main Board in September 2010 , CMS advances with formidable momentum onto the international capital platform, which will attract funds focusing on Asia-Pacific investments and local capital in Southeast Asia to optimize the shareholder structure. This listing also marks a significant milestone for the Group to deepen roots in emerging markets and advance industrial internationalization strategy.At the listing ceremony, Chairman, Chief Executive Officer and President of CMS, Mr. Lam Kong stated: “The secondary listing in Singapore represents a crucial step in implementing CMS’s Asia-Pacific strategy, demonstrating our commitment to extending China’s market advantages across the entire APAC region while strengthening our presence in Southeast Asia and the Middle East. This move not only facilitates CMS’s comprehensive and sustainable development in Asia-Pacific markets, but also enhances our international influence and competitiveness, enabling us to serve broader patient populations with high-quality and affordable medication options.”        New CMS New AscentOver the 33-year journey, CMS has continuously challenged and surpassed itself through three strategic transformations to adapt to the external ecosystem: evolving from “China’s largest CSO” (1992-2010), to “transition from CSO to Pharma” (2010-2018), and since 2018, gradually establishing three core strategies of “Innovation-driven, Specialty Breakthroughs and Industrial Internationalization” to promote the upgrading and iteration of “New CMS”, accumulating momentum for takeoff.CMS has established a comprehensive pharmaceutical product lifecycle management system, covering every stage from target identification to clinical development, product registration and commercialization. The Group focuses on FIC (First-in-Class) and BIC (Best-in-Class) innovative products, and has meticulously built a pipeline of approximately 40 innovative products with differentiated advantages, among which 5 innovative drugs have been approved and successfully commercialized in China. With the impact of VBP (Volume-Based Procurement) mostly cleared, CMS has entered a new cycle of high-quality and sustainable development driven by exclusive and innovative drugs.In specialty fields, the Group focuses on cardio-cerebrovascular, gastroenterology, ophthalmology and skin health, continuously deepening product portfolios and expert networks. Notably, the Group’s skin health business “DERMAVON” has emerged as a leader in its sector and is proposed for an independent listing on the Main Board of the Hong Kong Stock Exchange.A Pioneer in Industrial Internationalization Synergized Development Across the Entire “R&D, Manufacturing and Commercialization” Value ChainSince 2022, CMS has initiated its “Industrial Internationalization” strategy by extending the Group’s advantages and resources from the Chinese market to emerging markets. Utilizing Singapore as the strategic pivot, the Group has established a localized cluster comprising CMS R&D, PharmaGend, and Rxilient, achieving synergized development across the entire pharmaceutical value chain from R&D to production and commercialization, driving deeper and broader market expansion across the Asia-Pacific region.Internationalization of the Commercialization System: Rxilient serves as a platform for drug introduction, R&D and commercialization, operated by a professional and experienced localized team. Headquartered in Singapore, its business has expanded to 14 countries and regions including Malaysia, Thailand, Vietnam, the Philippines, Indonesia, and the Middle East, helping partners from China, the US, and Europe bring innovative drugs to emerging markets while introducing more high-quality and affordable treatment options to local markets. As of now, Rxilient has cumulatively submitted marketing applications for nearly 20 drugs and medical devices across Southeast Asia, the Middle East, Hong Kong, Macao and Taiwan, covering therapeutic areas such as dermatology, ophthalmology, oncology, autoimmune, and central nervous system.Internationalization of the Production System: PharmaGend, as an international CDMO platform based in Singapore, has a site spanning 30,000 square meters and is capable of manufacturing dosage forms such as tablets and capsules, with plans to expand production lines for injections, ointments, and nasal sprays. The factory has been certified by international authorities such as the FDA and the HSA, demonstrating its high-standard pharmaceutical manufacturing capabilities for global export .Structural factors including large population bases, healthcare insurance expansion and rising chronic disease burdens are transforming Southeast Asia, the Middle East and other emerging markets into new growth engines for the global pharmaceutical industry. Leveraging its integrated ecosystem, CMS is forming a novel model for Chinese pharmaceutical globalization - not only enabling incremental market conversion for its own products in emerging markets, but also providing global partners with a reliable one-stop solution, thereby generating additional growth momentum for the Group.Looking ahead, CMS will continue advancing its three core strategies to build the long-term value system of “New CMS”. By persistently enhancing accessibility to pharmaceutical innovation, CMS aims to benefit more patients, achieve sustainable healthy development, and deliver substantial value returns to investors.CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/Source: China Medical System Holdings Ltd. Copyright 2025 ACN Newswire via SeaPRwire.com.

WEST PALM BEACH, FL AND WINDSOR, ENGLAND, July 15, 2025 - (ACN Newswire via SeaPRwire.com) - U.S. Polo Assn., the official brand of the United States Polo Association (USPA), in partnership with Brand Machine Group (BMG), its licensing partner in the United Kingdom, proudly served once again as the Official Apparel and Team Sponsor for the 2025 Outsourcing Inc. Royal Charity Polo Cup. The prestigious event took place on July 11 at the renowned Windsor Great Park at Flemish Farms' Guards Polo Club.U.S. Polo Assn.(left to right) U.S. Polo Assn. Team Accepts Royal Charity Polo Cup Trophy: James Beim, HRH The Prince of Wales, J. Michael Prince (USPA Global), Boo Jalil (BMG), Aiyawatt Srivaddhanaprahba, and Amr ZedenIn its seventh consecutive year of sponsorship for the charitable event, U.S. Polo Assn. outfitted all participating polo players, umpires, and flaggers in custom-designed performance jerseys, with The Prince of Wales captaining the U.S. Polo Assn. Team. The annual event brought together elite polo players and distinguished guests for a day of sport and charitable giving.His Royal Highness The Prince of Wales competed in an exciting round-robin format match against Team Fortunis Bloodstock and Team Manta Marine Technologies - La Ilusión Polo Club. The high-profile charitable event featured other well-known polo players, including James Beim, Henry Porter, Jack Richardson, and Ivan Rubinich, to name a few. The match was filled with excellent gameplay from all participants, concluding with The Prince of Wales scoring the game-winning goal against Manta Marine Technologies. The Royal Charity Cup's Most Valuable Player was Emma McCrae from Team Fortunis Bloodstock, who had a great neck-shot goal during the day, alongside the Best Polo Pony, Chechu, played by HRH and owned by King Power Polo.In addition to performance gear, U.S. Polo Assn. provided a limited-edition 135th Anniversary commemorative gift to all event attendees, celebrating the brand's storied heritage dating back to 1890. The tailored gift set included a canvas tote bag, a 135th Anniversary cap, a pocket square, a lapel pin, the brand's newest issue of Field X Fashion magazine, as well as co-branded event caps developed exclusively for this occasion."It is an extraordinary honor to once again have The Prince of Wales lead the U.S. Polo Assn. Team in support of this meaningful charity event," said J. Michael Prince, President and CEO of USPA Global, the company which manages the global, multi-billion-dollar U.S. Polo Assn. brand. "We are proud to stand alongside our partner Brand Machine Group in raising critical funds and awareness through the sport of polo for very important causes that uplift communities across the United Kingdom."The annual high-profile philanthropic event raised more than £1.1 million for 10 important charities that are supported by The Prince and Princess of Wales. The 2025 event contribution takes the total raised from Royal Charity Polo Days played in the U.K. over the last 14 years to more than £14 million.Those charities include: Anna Freud Centre, British Red Cross, Child Bereavement UK, East Anglia's Children's Hospices, Family Action, Fields in Trust, Forward Trust, NHS Charities Together, Royal African Society, and We Are Farming Minds.In addition to U.S. Polo Assn.'s role as the Official Apparel and Team Sponsor, the 2025 Outsourcing Inc. Royal Charity Polo Cup was supported by a distinguished lineup of sponsors, including Lugano Diamonds, AUDI, and Whispering Angel. These prestigious brands joined forces to help elevate the experience for players and guests alike, while reinforcing the event's charitable mission through their shared commitment to excellence, philanthropy, and style."Participating in the 2025 Outsourcing Inc. Royal Charity Polo Cup again is one of the highlights of the British polo season for Brand Machine Group," said Boo Jalil, CEO of Brand Machine Group. "As the U.K. partner of U.S. Polo Assn., we are honored to help further connect the brand with the sport of polo and continue our shared mission of giving back through style and sport."Guards Polo Club is one of only four polo clubs in the United Kingdom that stage elite tournaments, such as the Royal Charity Polo Cup. Founded in 1955 as the Household Brigade Polo Club, with His Royal Highness Prince Philip, Duke of Edinburgh as President, the name was changed to the Guards Polo Club in 1969 and celebrates over six decades of premier polo.About U.S. Polo Assn. and USPA GlobalU.S. Polo Assn. is the official brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890 and based at the USPA National Polo Center in Wellington, Florida. This year, U.S. Polo Assn. celebrates 135 years of sports inspiration alongside the USPA. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,100 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. Historic deals with ESPN in the United States and Star Sports in India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, NBA, and MLB, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global and digital growth. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world. For more information, visit uspoloassnglobal.com and follow @uspoloassn.USPA Global is a subsidiary of the USPA and manages the global, multi-billion-dollar U.S. Polo Assn. brand. Through its subsidiary Global Polo Entertainment (GPE), USPA Global also manages Global Polo TV, which provides sports and lifestyle content. For more sports content, visit globalpolo.com.About Brand Machine Group (BMG)BMG is an international leader in fashion innovation, which has established itself as a vertical manufacturer and global licensing specialist with over four decades of industry experience. Partnering with recognized market leaders, BMG manages a seamless and collaborative process of designing, manufacturing, and delivering quality products while championing the DNA of a diverse portfolio of brands, spanning fashion, sports, outdoor, and homeware, including adult fashion, kidswear, and accessories.BMG's portfolio of brands includes U.S. Polo Assn. Penfield, New Balance Kids, Duchamp, Jack Wills, Flyers American Born, Lee Kids, Peckham Rye, Wrangler Kids, Juicy Couture. BMG reaffirms its commitment to upholding sustainable and ethical business practices by ensuring full transparency throughout its global supply chain, aligning with the ETI Base Code.Visit brandmachinegroup.com and follow @brandmachinegroup. For appointments, contact sales@brandmachinegroup.com.Photo Captions:1. (left to right) U.S. Polo Assn. Team Accepts Royal Charity Polo Cup Trophy: James Beim, HRH The Prince of Wales, J. Michael Prince (USPA Global), Boo Jalil (BMG), Aiyawatt Srivaddhanaprahba, and Amr Zeden2. HRH The Prince of Wales and Aiyawatt Srivaddhanaprahba Competing in the 2025 Outsourcing Inc. Royal Charity Polo Cup at Windsor Great Park at Flemish Farms' Guards Polo ClubPhoto Credit: Chris Jackson/Getty Images for Outsourcing Inc. Royal Charity Polo CupContact InformationShannon StilsonVP, Sports Marketing and Mediasstilson@uspagl.com+001.561.227.6994Gina DigregorioHead of Marketinggina.digregorio@brandmachinegroup.com+44 (0) 7741 635 984Stacey KovalskyVP, Global PR & Communicationsskovalsky@uspagl.com+001.561.790.8036SOURCE: U.S. Polo Assn.Related ImagesU.S. Polo Assn.HRH The Prince of Wales and Aiyawatt Srivaddhanaprahba Competing in the 2025 Outsourcing Inc. Royal Charity Polo Cup at Windsor Great Park at Flemish Farms’ Guards Polo Club Copyright 2025 ACN Newswire via SeaPRwire.com.

ROMEOVILLE, IL, July 15, 2025 - (ACN Newswire via SeaPRwire.com) - Formerra, a leader in performance materials distribution, today announced an agreement with GEON® Performance Solutions that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in North America and South America.The agreement follows GEON's acquisition of Foster, LLC, and builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials."This expanded partnership equips our customers with a broader set of proven medical-grade solutions while leveraging Formerra's technical guidance and robust supply-chain capabilities," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Foster's brand strength and GEON's investment momentum create powerful growth potential for these materials and our customers."Foster, LLC brings more than 30 years of expertise in custom medical polymer compounding, offering highly engineered formulations. Ranging from radio-opaque and pre-colored to USP Class VI and ISO 10993-compliant grades, Foster materials serve critical applications such as medical device housings, drug-delivery and auto-injector components, surgical tools, and remote patient monitoring devices."It is a privilege to serve the high-growth healthcare and medical device industry as GEON embarks on this new journey with Foster and Formerra," said Arthur Adams, Chief Commercial Officer, GEON. "Our partnership with Formerra will expand our global footprint and enable us to distribute medical-grade engineered polymers to even more customers."With the addition of Foster, LLC compounds to its portfolio, Formerra further deepens its leading position in the healthcare space by delivering unmatched access to engineered medical polymers, deep regulatory expertise, and responsive logistics across the Americas.Key details--Formerra will distribute Foster®, LLC medical compounds in North and South America.--This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.--Foster®, LLC material applications include medical device housings, drug-delivery and auto-injectors, surgical tools, remote patient monitoring components, and more.About FormerraFormerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.About GEONGEON® Performance Solutions is a global leader in the formulation, development and manufacture of performance polymer solutions. With a portfolio of highly adaptable vinyl and polyolefin polymer technologies as well as a full-service manufacturing business, GEON combines three powerful traditions into a single, customer-focused business. GEON Performance Solutions is a leading innovator in the development of performance material solutions for a broad range of markets including appliances, building & infrastructure, electronics, medical, transportation, power & communications and more. GEON Performance Solutions has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Please visit us at www.geon.com to learn more. GEON Performance Solutions is a portfolio company of SK Capital Partners.Media ContactJackie MorrisMarketing Communications Manager, Formerrajackie.morris@formerra.comSOURCE: Formerra Copyright 2025 ACN Newswire via SeaPRwire.com.

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsinLead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of actionVILNIUS, Lithuania, July 15, 2025 - (ACN Newswire via SeaPRwire.com) - AATec Medical GmbH ("AATec"), a biotech company developing a multi-product platform for the treatment of respiratory diseases, and Northway Biotech ("Northway Biotech" or "NBT"), a global Contract Development and Manufacturing Organization (CDMO), today announced a partnership for manufacturing process development and analytical development of AATec's lead product candidate, ATL-105, a proprietary, inhaled therapy based on recombinant alpha-1 antitrypsin (AAT) for non-cystic fibrosis bronchiectasis (NCFB).AATec Medical and Northway Biotech Announce PartnershipUnder the agreement, Northway Biotech will leverage its expertise in biologics manufacturing to develop and scale the production process for ATL-105 using the Pichia pastoris expression system."With this partnership, we are establishing a robust and scalable production process for ATL- 105, laying the foundation for consistent quality for clinical development and commercial use," says Rüdiger Jankowsky, PhD, co-founder and CEO of AATec, and adds: "ATL-105 represents a new generation of inhaled biologics, combining anti-protease, anti-inflammatory, and antiinfective properties in one molecule. Delivered directly to the lungs, it enables fast, targeted action with minimal systemic exposure. We believe ATL-105 can redefine care in respiratory diseases with high medical need, such as non-CF bronchiectasis.""We are excited to support AATec in progressing towards clinical trials", shares Prof. Vladas Algirdas Bumelis, CEO and Chairman of Northway Biotech. "AATec is advancing a promising therapeutic solution addressing significant unmet medical needs, supported by a highly capable and dedicated team. With our decades of expertise in microbial systems, we are well-positioned to scale this program efficiently and deliver quality at every step.""We have recognized the opportunity to support a program that could meaningfully advance care for patients with respiratory diseases," adds André Markmann, PhD, VP of Business Development at Northway Biotech. "Inhaled protein therapies are gaining significant traction, and ATL-105 stands out as one of the most promising approaches in this area."AATec develops ATL-105 to treat NCFB, a chronic inflammatory respiratory condition which affects millions of people worldwide. This debilitating disease is marked by dilated bronchi, persistent inflammation, frequent airway infections and impaired mucus clearance. In addition to NCFB, ATL-105 has therapeutic potential for a broader range of inflammatory and infectious respiratory diseases, such as COPD, ARDS and other indications, reflecting the versatility of its anti-inflammatory, immunomodulatory, and anti-infective properties.About AATec MedicalAG AATec Medical GmbH is a biotechnology company developing a product platform based on a novel recombinant version of alpha-1 antitrypsin (AAT) for the treatment of respiratory inflammatory diseases, airway infections and rare diseases. The company has successfully demonstrated proof-of-principle in several indications and is currently preparing for a proof-ofconcept clinical trial with the first product candidate ATL-105 for inhaled application in non-CF bronchiectasis. AATec was founded by a seasoned interdisciplinary team with long-standing experience in clinical research, biopharmaceutical development and product industrialization. For further information, please visit https://www.aatec-medical.com/ and follow AATec on LinkedIn.About Northway BiotechNorthway Biotech is a leading CDMO specializing in protein-based biologics and gene therapies, offering comprehensive, end-to-end biopharmaceutical development and manufacturing services. With deep expertise in cell line development, process optimization, and cGMP manufacturing, Northway Biotech supports programs from early-stage development through to commercial production. Founded in 2004, the privately held company operates state-of-the-art facilities in Lithuania and the United States, delivering high-quality, compliant solutions tailored to each client's unique needs. For further information, please visit https://www.northwaybiotech.com.Northway Biotech Contact:Prof. Vladas Algirdas BumelisCEO and Chairman of the Boardvladas.bumelis@northwaybiotech.comAATec Medical Contact:Dr. Rüdiger Jankowsky, CEOinfo@aatec-medical.comMedia Contact:MC ServicesKatja Arnold, Julia von Hummelaatec-medical@mc-services.euPhone: +49 (0)89 2102280SOURCE: Northway Biotech Copyright 2025 ACN Newswire via SeaPRwire.com.

双方建立合作关系，以开发并扩大 ATL-105 的生产规模。ATL-105 是一种新型重组 α1-抗胰蛋白酶。主要适应症为非囊性纤维化支气管扩张症；ATL-105 通过广泛的多模式作用机制，靶向疾病驱动因素。立陶宛维尔纽斯, 2025年7月16日 - (亚太商讯 via SeaPRwire.com) - AATec Medical GmbH（简称“AATec”）是一家致力于开发用于治疗呼吸系统疾病的多产品平台的生物技术公司。 Northway Biotech（简称“Northway Biotech”或“NBT”）是一家全球合同开发与制造组织（CDMO）。两家公司今日宣布建立合作关系，联合开展 AATec 旗下主要候选产品 ATL-105 的生产工艺开发与分析方法开发。ATL-105 是一种专有的重组 α1-抗胰蛋白酶（AAT）吸入式疗法，适用于治疗非囊性纤维化支气管扩张症（NCFB）。AATec Medical 与 Northway Biotech 宣布合作根据协议，Northway Biotech 将利用其在生物制剂生产方面的专业知识，采用毕赤酵母（Pichia pastoris）表达系统开发并扩大 ATL-105 的生产工艺。AATec 联合创始人兼首席执行官、博士 Rüdiger Jankowsky 表示：“通过此次合作，我们正在建立一套稳健且可扩展的 ATL-105 生产工艺，为临床开发和商业化应用奠定一致的质量基础。”他补充道：“ATL-105 代表新一代吸入式生物制剂，在单一分子中结合抗蛋白酶、抗炎和抗感染特性。通过直接递送至肺部，实现快速、精准的作用，并最大程度减少全身暴露。我们相信，ATL-105 有望重新定义如非囊性纤维化支气管扩张症等高未满足医疗需求呼吸疾病的治疗方式。”Northway Biotech 首席执行官兼董事长 Vladas Algirdas Bumelis 教授表示：“我们非常高兴能支持 AATec 向临床试验迈进。AATec 正在推进一项极具前景的治疗方案，旨在应对显著的未满足医疗需求，并拥有一支高效且敬业的团队。凭借我们在微生物系统方面数十年的专业经验，我们有能力高效扩大该项目的生产规模，并在每一个环节确保质量。”Northway Biotech 商务拓展副总裁、博士 André Markmann 补充道：“我们意识到这是一个有潜力显著改善呼吸系统疾病患者护理方式的项目，并希望为其提供支持。吸入式蛋白质疗法正日益受到关注，而 ATL-105 是该领域最具前景的方法之一。”AATec 正在开发 ATL-105，用于治疗非囊性纤维化支气管扩张症（NCFB）——这是一种慢性炎症性呼吸系统疾病，影响着全球数百万患者。该疾病表现为支气管扩张、持续性炎症、频繁的气道感染以及黏液清除功能受损。除了 NCFB 之外，ATL-105 还具有治疗更广泛炎症性和感染性呼吸系统疾病的潜力，例如慢性阻塞性肺疾病（COPD）、急性呼吸窘迫综合征（ARDS）以及其他适应症，充分体现了其抗炎、免疫调节和抗感染的多重作用机制与广泛适用性。关于 AATec MedicalAATec Medical GmbH 是一家生物技术公司，致力于开发以新型重组 α1-抗胰蛋白酶（AAT）为基础的产品平台，用于治疗呼吸道炎症性疾病、气道感染以及罕见病。公司已在多个适应症中成功验证其概念可行性，目前正在为首个候选产品 ATL-105（用于吸入式治疗非囊性纤维化支气管扩张症）开展概念验证临床试验做准备。AATec 由一支在临床研究、生物制药开发和产品产业化方面具有丰富经验的跨学科团队创立。欲了解更多信息，请访问： https://www.aatec-medical.com/ 并关注 AATec 的 LinkedIn页面。关于 Northway BiotechNorthway Biotech 是一家领先的合同开发与制造组织（CDMO），专注于蛋白质类生物制剂和基因疗法，提供全面的一站式生物制药开发与生产服务。公司在细胞株开发、工艺优化以及 cGMP 生产方面拥有深厚专业知识，支持从早期开发到商业化生产的各阶段项目。Northway Biotech 成立于 2004 年，是一家私人控股企业，在立陶宛和美国设有先进的生产设施，能够根据客户的独特需求提供高质量、合规的解决方案。欲了解更多信息，请访问：https://www.northwaybiotech.com   。Northway Biotech 媒体联系:Prof. Vladas Algirdas BumelisCEO and Chairman of the Boardvladas.bumelis@northwaybiotech.comAATec Medical 媒体联系:Dr. Rüdiger Jankowsky, CEOinfo@aatec-medical.com媒体联系:MC ServicesKatja Arnold, Julia von Hummelaatec-medical@mc-services.euPhone: +49 (0)89 2102280来源: Northway Biotech Copyright 2025 亚太商讯 via SeaPRwire.com.

深圳，2025年7月15日 - (亚太商讯 via SeaPRwire.com) - 7月15日上午，康哲药业控股有限公司（"康哲药业"或"集团"）在新加坡交易所正式鸣锣上市（证券简称：CMS，股票代码：8A8）。近百名全球专业机构代表、股东代表、合作伙伴代表以及员工代表，共同见证这一具有战略意义的时刻。这是康哲药业继2010年9月成功登陆香港联交所主板之后，再度以磅礴之势迈向国际资本平台，将吸引专注亚太投资的基金及东南亚本土资本，优化股东结构。同时，也标志着集团深耕新兴市场、推进产业国际化战略的重要里程碑。康哲药业主席兼行政总裁、总裁林刚先生在上市仪式现场致辞："在新加坡的二次上市，标志着康哲药业实施亚太战略迈出了关键一步，彰显了我们将中国市场优势延伸至整个亚太地区、深化东南亚及中东布局的决心。这不仅助力康哲药业在亚太市场全方位、可持续发展，更提升了公司的国际影响力与竞争力，使我们能够覆盖更广泛的患者群体，为他们提供优质、可负担的用药选择。"新康哲 新崛起三十三年征程，康哲药业通过三次战略转型不断挑战与超越以适配外部生态：从"中国最大CSO"（1992-2010年），到"从CSO向Pharma转换"（2010年起-2018年），再到自2018年起，逐步确立"创新驱动、专科突破、产业国际化"三大核心战略，推动"新康哲"升级迭代，蓄势而发。康哲药业已建立医药产品全生命周期管理体系，覆盖从靶点识别到临床开发，再到产品注册及商业化推广的每一个环节。集团专注FIC、BIC创新产品，精心打造了约 40 款具有差异化优势的创新产品管线，其中 5 款创新药已在中国获批并成功商业化。随着集采影响基本出清，康哲药业已进入由独家药、创新药驱动的高质量、可持续发展新周期。专科方面，集团聚焦心脑血管、消化、眼科、皮肤健康等领域，持续深化产品布局与专家网络。值得一提的是，集团皮肤健康业务"德镁医药"，已在细分领域崭露头角，成为行业领军者，并计划于香港联交所主板独立上市。产业国际化出海先锋"研、产、销"全链条协同发力自2022年起，康哲药业启动"产业国际化"战略，将集团在中国市场的优势与资源外溢至新兴市场，并以新加坡为支点，建立涵盖CMS R&D、PharmaGend以及Rxilient在内的本地化集群，实现医药产业"研、产、销"全链条协同发力，放眼全亚太拓展市场深度与广度。商业化体系国际化：Rxilient为药品引进、开发、营销推广平台，由专业、经验丰富的本土化团队运营，以新加坡为总部，业务已拓展至马来西亚、泰国、越南、菲律宾、印尼、中东等14个国家和地区，助力中、美、欧等地合作伙伴的创新药落地新兴市场，同时为当地引入更多优质、可负担的治疗选择。截至目前，Rxilient在东南亚、中东、港澳台地区累计提交了近20款药品和医疗器械的上市申请，覆盖皮肤科、眼科、肿瘤、自身免疫、中枢神经等疾病领域。生产体系国际化：PharmaGend作为国际化CDMO平台，以新加坡为基地，拥有3万平方米生产场地，可生产片剂、胶囊等剂型，并规划拓展注射剂、软膏剂、鼻喷剂等产线，工厂已通过FDA、HSA等国际认证，具备面向全球输出的高标准药品制造能力。庞大人口基数、医保扩容与慢病负担上升等结构性因素，正推动东南亚、中东等新兴市场成为全球医药产业新增长极。康哲药业依托全链条生态体系，正逐步形成中国医药产业出海的新模式，不仅赋能自身产品的新兴市场增量转化，也为全球合作伙伴提供可信的一站式落地机制，为集团注入额外的增长动能。展望未来，康哲药业将持续推动三大核心战略以构建"新康哲"长期价值体系，不断提升医药创新可及性，助力更多患者获益，实现可持续健康发展，并为投资者创造丰厚价值回报。康哲药业免责与前瞻性声明本新闻无意向您做任何产品的推广，非广告用途。本新闻不对任何药品和医疗器械和/或适应症作推荐。若您想了解具体疾病诊疗信息，请遵从医生或其他医疗卫生专业人士的意见或指导。医疗卫生专业人士作出的任何与治疗有关的决定应根据患者的具体情况并遵照药品说明书。由康哲药业编制的此新闻不构成购买或认购任何证券的任何要约或邀请，不形成任何合约或任何其他约束性承诺的依据或加以依赖。本新闻由康哲药业根据其认为可靠之资料及数据编制，但康哲药业并无进行任何说明或保证、明述或暗示，或其他表述，对本新闻内容的真实性、准确性、完整性、公平性及合理性不应加以依赖。本新闻中讨论的若干事宜可能包含涉及康哲药业的市场机会及业务前景的陈述，该等陈述分别或统称为前瞻性声明。该等前瞻性声明并非对未来表现的保证，存在已知及未知的风险、不明朗性及难以预知的假设。康哲药业并不采纳本新闻包含的第三方所做的任何前瞻性声明及预测，康哲药业对该等第三方声明及预测不承担责任。 Copyright 2025 亚太商讯 via SeaPRwire.com.

Forum will take place on Tuesday 22 July 2025, from 1:30 PM onwards, at Suntec Singapore Convention & Exhibition Centre, Level 3Guest-of-Honour, Ms Low Yen Ling, Senior Minister of State, Ministry of Culture, Community and Youth & Ministry of Trade and Industry will deliver keynote addressThis year’s theme is Industry, Business, and Regulatory Perspectives on Climate Change Mitigation and AdaptationSINGAPORE, July 15, 2025 - (ACN Newswire via SeaPRwire.com) - ONERHT Foundation has announced the 8th edition of the Greening ASEAN: Initiatives and Leadership (“GAIL”) Forum, which will take place on Tuesday 22 July 2025 from 1:30 PM at the Suntec Singapore Convention & Exhibition Centre, Level 3 (Rooms 334 to 336). The upcoming forum will gather business leaders, policymakers, and sustainability experts from across the region to examine industry, business, and regulatory perspectives on climate mitigation and adaptation in ASEAN. The forum will be graced by Ms Low Yen Ling, Senior Minister of State, Ministry of Culture, Community and Youth & Ministry of Trade and Industry, as the Guest-of-Honour, who will deliver the keynote address.This year’s theme explores Industry, Business, and Regulatory Perspectives on Climate Change Mitigation and Adaptation. Participants can look forward to an engaging half-day programme featuring keynotes and discussions focused on navigating the challenges and opportunities presented by sustainability imperatives, climate regulations, and evolving business models. The forum provides a unique opportunity to understand emerging trends, collaborate across sectors, and build capacity for lasting environmental impact.Ms Ch’ng Li-Ling, Director of RHT GRACE Institute, said, “Sustainability has moved to the centre of business strategy. It now underpins long-term value creation and corporate resilience.” Ms Kaylee Kwok, Chairman of ONERHT Foundation, said, “As ONERHT Foundation marks its 10th anniversary this year, our annual GAIL Forum continues to drive these critical conversations, equipping business and government leaders with the tools to lead effectively in a rapidly evolving landscape.”Key highlights of this year’s forum will be a fireside chat entitled “The Future of Green Leadership in ASEAN – How Businesses and Professional Services Can Drive Impact”, “Presentation on Navigating ASEAN’s Green Transition: Legal and Policy Pathways”, and “Developing and Investing in Carbon Markets in Asia: Business and Regulatory Perspectives”, featuring distinguished leaders and speakers in sustainability and governance. The sessions will spotlight practical and visionary approaches needed to catalyse meaningful climate action across the region.Launched by ONERHT Foundation in 2018, the GAIL Forum has grown into an annual platform for advancing climate resilience and sustainable business practices across ASEAN. By convening industry leaders and policymakers, the forum equips businesses with the knowledge, strategies, and confidence to embed sustainability at the core of their operations.For more information and to register for the ONERHT Foundation GAIL Forum 2025, please visit: https://www.gail2025.com/ ONERHT Foundation LtdA Singapore registered charity and grant-making philanthropic organisation, ONERHT Foundation Ltd (“Foundation”) enables RHTLaw Asia LLP and the RHT Group of Companies (collectively, “ONERHT”) to do right and do good through various charitable endeavours. Set up by ONERHT in 2015, the Foundation was registered as a Singapore charity by the Commissioner of Charities and a grant-making philanthropic organisation by the Inland Revenue Authority of Singapore on 16 September 2016 and 28 November 2016 respectively. The Foundation seeks to establish, inspire and encourage the right philanthropic culture among the corporate and legal fraternity of giving back to the community in a focused, hands-on and meaningful manner. Since its inception, the Foundation has raised more than S$5.5 million to support more than 35 beneficiaries involved in education, the environment protection and sustainability, disadvantaged groups as well as the arts and sports. For more information, please visit www.onerht.foundationRHT GRACE Institute LtdRHT GRACE Institute (“RGI”) is a social enterprise launched by ONERHT Foundation Ltd in 2020. RGI seeks to establish a culture and creed of raising consciousness, encouraging ethical leadership, and growing a community of values-aligned mindfully ethical leaders, professionals, and businesses. The mission of RGI is anchored on the core principles based on Governance, Risk, AML, Compliance & ESG (G.R.A.C.E.) within an organisation’s business model, infusing these into its culture, and influencing and impacting leaders, professionals and individuals by setting a precedent and standard for what is expected in decision making and behaviour. The vision of RGI elevates an organization from good to great, embedding its principles in members’ business models, organizational strategy and decision-making processes and influencing them to become custodians and champions of G.R.A.C.E. principles. RGI runs the podcast “EthBeats: Lessons in G.R.A.C.E.ful Living”.For media enquiries, please contact: Melody Ong / melody@waterbrooks.com.sg  / +65 8901 9780General enquiries query@waterbrooks.com.sg  Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, July 15, 2025 - (ACN Newswire via SeaPRwire.com) - The Payment Cards Group Limited (“PCG”), a cloud-native payment processor and acquirer, is reshaping the digital payment landscape through disruptive innovation, powering Hong Kong’s digital transformation and smart city development. In June 2025, PCG’s digital payment acceptance business, Yedpay, collaborated with Big Boss Taxi, a taxi fleet operator to introduce a wide range of digital payment options including Octopus, revolutionizing taxi payment experience and ushering the transportation sector into a new digital era. In addition, Yedpay’s solutions empowered Hong Kong’s first floating bar, STAY BAR, to break away from traditional business models, significantly enhancing customer experience and driving revenue growth. In June, PCG and its member, BBMSL, celebrated their relocation to a new office, marking a new chapter in the Group’s development. With innovation at its core, PCG is transforming Hong Kong’s payment ecosystem, guiding industries to embrace the digital era and paving the way for a brighter future as a smart city.Yedpay collaborates with Big Boss Taxi to promote cashless taxi paymentsAs an acquirer with principal memberships in all major card schemes, Yedpay delivers tailored digital payment solutions for diverse industries. Octopus Holdings Limited recently announced a partnership with Big Boss Taxi to launch a comprehensive taxi ecosystem solution that integrates ride-hailing, digital payments, and more. PCG, in collaboration with Big Boss Taxi, integrated POS terminals with taxi meters to support multiple payment methods, including Octopus, credit cards, and e-wallets, enabling seamless and efficient taxi payments for passengers. Big Boss Taxi will launch full services in July, offering passengers a frictionless ride experience powered by cashless payments. Digital payments fuel revenue growth for local barBeyond its collaboration with local taxi fleet operator, Yedpay assisted STAY BAR, Hong Kong’s first floating bar, seize the trend of digital consumption, thereby attracting more tourists and local customers and contributing to continuous revenue growth. By supporting over 21 payment methods, including Alipay, WeChat Pay, and credit cards, Yedpay enabled STAY BAR to deliver seamless and convenient checkout experience for a diverse clientele. With transparent pricing and prompt customer support, Yedpay further enhanced STAY BAR’s operational efficiency. Committed to advancing a cashless society, Yedpay provides flexible and innovative payment solutions that support sectors such as transportation, food and beverage, and retail, enhancing operational efficiency and customer experiences, and stimulating local spending amid sluggish consumption. Video link: https://www.facebook.com/share/r/19Lj6ZYPFp/New office: a milestone for innovation and growthIn June, PCG and its member BBMSL hosted a new office warming party, celebrating the successful relocation and fostering stronger connections among staff members. The new office not only enhances the working environment but also injects vitality into the Group’s innovation and collaboration efforts. PCG extends its gratitude for the support from all sectors and remains committed to delivering innovative payment solutions to more merchants, thereby advancing Hong Kong’s development as a smart city.PCG New Address:Suites 601-2 & 10-14, 6/F, North Tower, World Finance Centre, 19 Canton Road, Harbour City, Tsim Sha Tsui, Kowloon, Hong KongAbout Payment Cards Group (“PCG”)The Payment Cards Group Limited (“PCG”) is an innovative and leading payment technology company with operations in Singapore, Hong Kong and the Asia-Pacific region. Established in 2016, PCG has become an acquirer with principal memberships in all major card schemes and e-wallet networks. Yedpay, a member of PCG, has firmly established itself as a digital payment acceptance business in Hong Kong. Meanwhile, A3A, another member of PCG, has developed a cloud-native payment processing platform that operates through RESTful APIs, significantly reducing costs and streamlining complex processes while providing users with real-time transaction data and insights. As an acquiring processor, PCG serves as the backbone infrastructure of the entire payment industry by its Asia’s 1st cloud-based processing and settlement platform. Rooted in Hong Kong with a global vison, PCG seeks to empower merchants with cutting-edge payment technology solutions and drive high-quality development in the global payment ecosystem. For more information, please visit PCG’s website: https://www.yedpay.com/en/For media enquiries, please contact:AJA (IR and Communications)Avy YuTel: (852) 9500 4443Email: avy.yu@ajacapital.com.hk/info@ajacapital.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.

Introduction: Accelerating progress in virtual asset management business in games and global expansion layout.HONG KONG, July 14, 2025 - (ACN Newswire via SeaPRwire.com) - Recently, Spruce Technology HK Limited, a wholly-owned subsidiary of Kingnet, was officially granted Type 4 (advising on securities) and Type 9 (asset management) licenses by the Securities and Futures Commission (SFC) in Hong Kong.A previous similar event that attracted widespread attention in Chinese mainland occurred in December last year, when Zhang Yiming, co-founder of ByteDance, acquired a Hong Kong Type 9 license through a subsidiary "Cool River Venture HK Limited".Geographically, Hong Kong is expediting the process to become a global Web3.0 hub. For Kingnet, which is in an accelerated phase of gaming business globalization while aggressively deploying cutting-edge sectors such as metaverse and Web3.0, these two licenses will serve as pivotal fulcrum for its ecological upgrading: the company can not only attract more international partners to jointly develop AI-driven game development tools and PUGC platforms, but also carry out virtual asset generation in games, trading, and asset management businesses in full regulatory compliance, thereby bridging the "creativity-assets-finance" loop to build a trustable global digital economic ecosystem.License Is Not the DestinationForge A More Imaginative "Virtual Asset Manager In Games" Kingnet has long been actively exploring the deep integration of cutting-edge technologies and capital operations in emerging fields such as Web3.0 and metaverse. As early as 2023, Kingnet disclosed that it could support product integration with Web3.0 from a technical framework perspective, and would maintain sustained attention to the evolution of Web3.0 technologies.Additionally, Kingnet has proactively established a digital asset platform called "KINGNET CHAIN", dedicated to aggregating diverse creators and gaming brands through blockchain technology in conjunction with Web3.0, metaverse and artificial intelligence to construct a digital art marketing system, establish digital brand IDs, and create a rich and diversified metaverse content ecosystem. Up to now, "KINGNET CHAIN" has released multiple original IPs and brand collaboration digital artworks. By employing a sales model that integrates "digital assets with real economy", it promotes a deep convergence between digital economy and real economy.On the opening day of the 2024 Paris Olympics, the Olympic-themed digital assets series featuring Kingnet's mascot "K Xiao Huang" was exclusively launched in limited quantities on the "KINGNET CHAIN", with the customized interactive digital asset mini-game "Olympic 'Huang' Family Supporters" simultaneously released. Users can earn exclusive and unique digital asset rewards through gameplay participation, and these digital assets will be intrinsically linked to platform privileges to pioneer a new pathway for the mass adoption and application of the digital assets.According to market data, "KINGNET CHAIN" has reached a milestone of nearly 200,000 identity-authenticated registered users. In the future, it can assist global market-oriented manufacturers in achieving overseas game digital asset distribution, form a dual-track model of "domestic regulatory-compliant distribution + multi-chain overseas circulation", and provide a one-stop solution spanning from technical infrastructure to trading scenarios for globalization of gaming assets.Prior to Kingnet's entry, representative overseas gaming companies had already validated the feasibility of this approach by obtaining financial licenses for layout of the virtual asset management business: Hong Kong's Web3 frontrunner Animoca Brands constructed a full-chain management system encompassing metaverse asset distribution and trading by acquiring relevant compliance qualifications. Mythical Games, founded by the former Activision Blizzard core team, has also established itself as a benchmark in the field of blockchain gaming for establishing closed-loop virtual asset value circulation through licensed compliance by implementing secure player asset ownership and trading leveraging the "invisible blockchain technology" under a compliant framework in flagship titles like Blankos Block Party.With the acquisition of Type 4 and Type 9 licenses, Kingnet may further broaden its business boundaries in relevant fields such as virtual social interaction and blockchain gaming. By generating assets through gaming behaviors and activating assets via financial licenses, the company is forming a closed-loop ecosystem, thereby evolving into a "More Imaginative Kingnet".Based on Existing Overseas Layout ExperienceBuild an Open and Credible Global PUGC PlatformFrom another perspective, Kingnet's globalization strategy had demonstrated tangible results even prior to acquiring SFC Type 4 and Type 9 licenses in Hong Kong.From the product side, the company has proactively seized overseas market opportunities, proactively deployed global distribution, targeted the global market, established in-depth partnerships with numerous overseas channels, and achieved remarkable results in overseas market expansion. It is understood that newly launched games in 2025, including MU Immortal, Party Beasts, etc., have topped overseas gaming charts immediately upon release, demonstrating formidable growth potential.The sequential launch of multiple new products is expected to further improve Kingnet's product matrix and gradually form differentiated competitiveness, thereby further expanding its market share and driving tiered user base growth. As reflected in its performance, Kingnet's overseas revenue reached RMB 375 million in 2024, achieving a year-on-year growth of up to 221.48%.To support these ambitions, Kingnet has launched Kingnet AI , an AI-Web3 game collaboration platform developed by SmileCobra Studio , a Singapore-based Web3 gaming studio and Kingnet’s exclusive strategic partner. Kingnet AI features a visual, no-code AI creation engine that allows developers and creators to build blockchain-based games from scratch, automate content generation, and deploy multi-chain assets seamlessly. Kingnet AI has already established strategic partnerships with TON, Solana,BNB Chain, and Alibaba Cloud.Combined with a series of actions of the company in game globalization, proprietary AI-powered development platform, etc., it can be speculated that the company will or may also create an AI-powered end-to-end game development toolkit and a PUGC player user platform overseas. The overseas user platform will target player communities by delivering AI-powered gaming products with diversified gameplay mechanics and innovative contents. With dual SFC financial licenses, the platform provides virtual economy systems where overseas developers can autonomously generate in-game tokens through the platform's system or games on the platform to assist game developers in refining the economic systems.From this perspective, Kingnet is hopeful to build a truly open and credible global PUGC platform and empower innovations in digital contents and economic systems based on its experience accumulated in overseas game operation & distribution over the past period and a deeper understanding of Web3.0 innovation models in overseas markets. Copyright 2025 ACN Newswire via SeaPRwire.com.

Brisbane, Queensland, Australia - (ACN Newswire via SeaPRwire.com - July 14, 2025) - Graphene Manufacturing Group Limited (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce that the patent for the Company's Graphene Aluminium Ion Battery has been granted in Australia and GMG is progressing its patenting process in various other countries. The University of Queensland (UQ) holds the patent and GMG has a worldwide exclusive commercialisation license. Figure 1 shows a typical Graphene Aluminium Ion Battery Pouch Cell Prototype which GMG is currently co-developing with Rio Tinto and UQ.Figure 1: Typical G+AI Battery Pouch Cell PrototypeTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/258713_gmg_figure1_550.jpgFurthermore, GMG has signed a Collaborative Research Agreement with UQ - Australian Institute for Bioengineering and Nanotechnology (AIBN) to continue its collaboration on the Graphene Aluminium Ion Battery. UQ is also a recipient of AU$880,000 of Australian Government grant funding to further develop the Graphene Aluminium Ion Battery.Figure 2To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/258713_gmg_figure2_550.jpgGMG and UQ started working on an Australian Research Council (ARC) Linkage Project in 2021 to co-develop the Graphene Aluminium Ion Battery and this will now continue under this new Collaborative Research Agreement.The Agreement sets out, among other things, the way in which pre-agreed GMG and UQ personnel can work at each other party's premises and the intellectual property rights and obligations for each party. It also provides that GMG has the exclusive first right to negotiate an exclusive license to use any of the work UQ develops under this Agreement.UQ's Professor Alan Rowan, AIBN Executive Director, commented "We look forward to continuing our strong research and development relationship with the world leading clean technology company GMG and deepening our knowledge on the graphene aluminium ion battery technology."GMG's Managing Director and CEO, Craig Nicol, commented: "GMG is very pleased to continue working with the world leading UQ AIBN team and collaborating with them to co-develop our next generation Graphene Aluminium Ion Battery."As previously announced on March 3, 2025, GMG has entered into a service contract with the Battery Innovation Center (BIC) of Indiana in the United States of America to support the next phase of development of the Graphene Aluminium Ion Battery. As a result, GMG is no longer focused on a project to construct an Automated Battery Pilot Plant at its Richlands Australia headquarters at this time. GMG and the State of Queensland have mutually agreed to an early termination of the Queensland Critical Minerals and Battery Technology Fund Agreement between the parties.About UQ & AIBN:Ranked in the world's top 50, The University of Queensland is one of Australia's leading research and teaching institutions. As part of UQ, the Australian Institute for Bioengineering and Nanotechnology (AIBN) is a leading research institute which tackles global challenges in health, energy, and the bioeconomy. It works on projects like mRNA manufacturing, diagnostics, and sustainable solutions. AIBN collaborates with industry and government and are known for their work in advanced biomanufacturing, nanoengineered materials, and precision nanomedicine.About GMG:GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed to improve the performance of lithium-ion batteries.GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking Statements This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, the development of the Graphene Aluminium Ion Battery Pouch Cell Prototype, the future collaboration between GMG and UQ-AIBN, the further development of the Graphene Aluminium Ion Battery and GMG's intentions for the Automated Battery Pilot Plant at its Richlands Australia headquarters, the further development of the Graphene Aluminium Ion Battery with the BIC of Indiana.Such forward-looking statements are based on a number of assumptions of management, including amongst others, the successful repeatability and scalability of the Graphene Aluminium Ion Battery cells, the successful electrochemistry optimisation of the Graphene Aluminium Ion Battery, the energy density of the Graphene Aluminium Ion Battery reaches the required performance level for customer adoption, successful customer adoption of the Graphene Aluminium Ion Battery, successful pilot plant and production scale up of the Graphene Aluminium Ion Battery, the Graphene Aluminium Ion Battery is competitive against other technologies with respect to cost, performance, safety and other parameters, the Graphene Aluminium Ion Battery safety is validated by external testing and customers, the Company is able to get the required approvals for production and sale of the Graphene Aluminium Ion Battery, the Graphene Aluminium Ion Battery expected costs are within acceptable range to produce and sell profitably, the Company can fund the capital required to produce the Graphene Aluminium Ion Battery at scale and global market trends continue to incentivise industries to adopt batteries for use. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: technical risks for the repeatability, scalability, electrochemistry optimisation and performance uncertainty, commercialisation risks for the pilot plant success, customer testing, market adoption and industry inertia, safety and regulatory risks for the safety validation and regulatory approvals, supply chain risks for the sourcing of raw materials and local manufacturing challenges, financial and market risks for the capital requirements and market volatility, risks relating to the extent and duration of the conflict in Eastern Europe and its impact on global markets, the volatility of global capital markets, political instability, attract and retain skilled personnel, unexpected development and production challenges, unanticipated costs and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated October 3, 2024 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/258713 Copyright 2025 ACN Newswire via SeaPRwire.com.

SINGAPORE, July 15, 2025 - (ACN Newswire via SeaPRwire.com) - Mooreast Holdings Ltd. (“Mooreast” or the “Group”) said today that it has partnered with Norway-based GeoProvider AS (“GeoProvider”) to strengthen capabilities in offshore data analysis and enhance its value proposition to the floating offshore renewable energy market.Through their Framework Agreement, Mooreast will tap into GeoProvider’s extensive geotechnical and geophysical database to accelerate data analysis and support larger, more complicated projects. Both parties will also collaborate on offshore wind projects as the floating renewable market transitions towards the commercialisation phase.SGX Catalist-listed Mooreast, a total mooring solutions specialist, has been offering geotechnical and geophysical studies, such as soil data analysis to determine project feasibility and engineering design for mooring configurations. The Group is also Asia’s only ultra-high power anchor manufacturer.Headquartered in Stavanger, Norway, GeoProvider provides geophysical data and geotechnical services for global clients involved in offshore wind, energy exploration and carbon capture and storage. Its team of world-class specialists and cutting-edge technology offers consultancy, advisory, and engineering for subsurface projects.Mr Eirik Ellingsen, CEO of Mooreast, said, “The agreement with GeoProvider reflects our strategy to build strong partnerships that add value to our clients and increase our capability to take on larger and more complex projects. GeoProvider’s strong track record complements our core competencies as a mooring specialist, allowing us to better meet the demands of the global offshore market.”In line with these efforts, Mooreast also signed a Memorandum of Understanding (“MoU”) with Korea Ocean Engineering & Consultants Co., Ltd. (“KOCECO”) to promote joint business and technology collaboration in offshore mooring and seabed anchoring solutions.KOCECO, recognised by South Korea’s Ministry of Trade, Industry and Energy, brings extensive experience in submarine cable laying and underwater engineering services. The MoU lays the groundwork for future cooperation in the rapidly developing floating offshore wind market in North Asia, where Mooreast seeks to play a pivotal role in addressing local supply chain gaps in mooring systems.“The two agreements will significantly strengthen Mooreast’s global position and our commitment to our transformation to serve the renewable energy sector. Through these partnerships, we are now better equipped to deliver a comprehensive solution for the offshore sector,” added Mr Ellingsen.This press release has been reviewed by the Company’s sponsor, UOB Kay Hian Private Limited (the “Sponsor”). This press release has not been examined or approved by the Singapore Exchange Securities Trading Limited (the “SGX-ST”) and the SGX-ST assumes no responsibility for the contents of this press release, including the correctness of any of the statements or opinions made or reports contained in this press release.The contact person for the Sponsor is Mr Lance Tan, Senior Vice President, at 83 Clemenceau Avenue, #10- 01 UE Square, Singapore 239920, telephone (65) 6590 6881.Issued for and on behalf of Mooreast Holdings Ltd. by WeR1 Consultants Pte Ltd.About Mooreast Holdings Ltd.Mooreast is a total mooring solutions specialist, serving mainly the offshore renewable energy, offshore oil & gas (“O&G”) and marine industries, with operations primarily in Singapore, the Netherlands through its wholly-owned subsidiary in Rotterdam Mooreast Europe, and offices based in Scotland, Taiwan and Malaysia.Mooreast’s solutions include the design, engineering, fabrication, supply and logistics, installation and commissioning of mooring systems. Mooreast is applying its experience and expertise in mooring solutions to floating renewable energy projects, in particular floating offshore wind farms. It has successfully participated in developmental and prototype projects for floating offshore wind turbines in Japan and Europe.For more information, please visit https://mooreast.com/Media & Investor Contact InformationWeR1 Consultants Pte Ltd1 Raffles Place #02-01One Raffles Place Mall Suite 411Singapore 048616Isaac Tang, mooreast@wer1.net (M: +65 9748 0688) Copyright 2025 ACN Newswire via SeaPRwire.com.

导语：加速游戏虚拟资产管理业务进程和全球化布局。香港，2025年7月14日 - (亚太商讯 via SeaPRwire.com) - 日前，恺英网络旗下全资子公司Spruce Technology HK Limited正式获香港证券及期货事务监察委员会(SFC)颁发第4类(就证券提供意见)及第9类(提供资产管理)牌照。上一个在内地引发广泛关注的类似事件，是去年12月字节跳动联合创始人张一鸣通过旗下"Cool River Venture HK Limited"斩获香港9号牌照。从地域来看，香港正加速推动成为全球Web3.0中心。对正处于游戏业务全球化加速期，且积极布局元宇宙、Web3.0等前沿赛道的恺英网络而言，这两个牌照将成为其生态升级的核心支点：公司不仅能吸引更多国际合作伙伴共同开发AI驱动的游戏开发工具与PUGC平台，更能合规开展游戏虚拟资产生成、交易及资产管理业务，从而打通"创意-资产-金融"闭环，构建可信赖的全球化数字经济生态。牌照不是终点 打造更具想象力的"游戏虚拟资产管理者"恺英网络长期以来一直积极探索Web3.0、元宇宙等新兴领域的前沿技术与资本运作深度融合。早在2023年，恺英网络就曾透露，其从技术框架上可支持产品接入Web3.0，并将持续关注Web3.0技术的发展。此外，恺英网络还早早搭建了数字资产平台「拾元立方」，致力于通过区块链技术并结合Web3.0、元宇宙和人工智能，汇集多方创作者和游戏品牌方，构建数字艺术品营销体系，建立数字品牌形象，打造丰富多元的元宇宙内容生态。截至目前，「拾元立方」已发布了多款原创IP和品牌联动数字艺术品，以"数字资产与实体经济"相结合的发售方式，促进数字经济与实体经济深度融合。2024年巴黎奥运会首日，恺英网络公司吉祥物"K小皇"奥运系列数字资产就在「拾元立方」独家限量首发，定制数字资产互动小游戏「奥运"皇"家助威团」同步上线。用户可以通过参与游戏获得专属独特的数字资产奖励，数字资产将绑定平台权益，为数字资产的普及和应用开辟了新的道路。根据市场数据，「拾元立方」现已拥有实名注册用户近20万，未来能够帮助出海厂商实现游戏数字资产海外发行，形成"国内合规发行+海外多链流通"的双轨模式，为游戏资产全球化提供从技术底层到交易场景的一站式解决方案。在恺英网络之前，海外代表性游戏公司已通过获取金融牌照布局虚拟资产管理业务，验证了这一路径的可行性：香港 Web3 头部企业 Animoca Brands 通过获取相关合规资质，构建了覆盖元宇宙资产发行、交易的全链条管理体系；由动视暴雪前核心团队创立的 Mythical Games，亦凭借合规框架下的"隐形化区块链技术"，在《Blankos Block Party》等代表作中实现玩家资产的安全持有与交易，成为区块链游戏领域通过牌照合规打通虚拟资产价值闭环的标杆。随着4号及9号牌照的获得，恺英网络或将进一步拓宽在虚拟社交、区块链游戏等相关领域的业务边界，用游戏行为产生资产，用金融牌照盘活资产，闭环生态形成，从而成为一个"更具想象力的恺英"。基于已有的海外布局经验 构建开放、可信的全球化PUGC平台从另一个角度来看，在本次获得香港SFC第4类及第9类牌照前，恺英网络的全球化战略就已显成效。从产品端来看，积极把握海外市场机遇，积极布局全球化发行，放眼全球市场，与众多海外渠道建立了深入合作关系，在海外市场拓展方面的成绩颇为亮眼。据了解，2025年新游《MU Immortal》《派对不兽控》等游戏均在上线伊始即登顶海外地区游戏榜单，成长实力不容小觑。多款新品的相继推出，有望进一步完善恺英网络的产品矩阵并逐渐形成差异化竞争力，从而进一步扩大市场份额，推动用户规模实现阶梯式增长。反映在业绩表现上，2024年恺英网络海外营收3.75亿元，同比增长多达221.48%。就在6月底，恺英网络向市场推出了一款专为游戏行业打造的AI全流程开发平台"SOON"。该平台凭借对多模态大模型能力的深度整合，实现了从美术资产生成到代码部署全流程的自动化操作，极大地缩短了传统游戏开发周期，充分赋能游戏行业向全自动AI转型。结合这家公司在游戏出海和自研AI开发平台等一系列动作，可以猜测，公司将在海外或也会打造AI全流程游戏开发工具和PUGC玩家用户平台，海外用户平台面向玩家群体，提供多玩法、多创意的AI游戏产品。在SFC两个金融牌照的加持下，平台提供虚拟经济系统，海外开发者可以通过平台系统或平台上的游戏自己生成游戏代币，帮助游戏开发者完善经济系统。从这个角度来看，基于过去一段时间在海外游戏运营发行积累的经验，以及海外市场对Web3.0创新模式更加深刻的理解，恺英网络有望构建一个真正开放、可信的全球化PUGC平台，赋能数字内容与经济系统的创新。 Copyright 2025 亚太商讯 via SeaPRwire.com.